Epidemiological studies have demonstrated that the risk of coronary artery disease (CAD) is
increased in smokers but reduced in individuals with elevated plasma levels of high density …

The effect associated with the substitution of adenine (A) for guanidine (G) in the promoter
region of the apolipoprotein AI gene (− 75 bp) with plasma apo AI and high‐density …

Elevated HDL-cholesterol (C) and apo AI are associated with decreased coronary artery
disease (CAD) risk. We determined distributions of two MspI polymorphisms of the apo AI …

The present study sought to resolve the contradictory evidence as to whether the G→ A
substitution at position− 75 of the apoA-I gene promoter raises HDL cholesterol (HDL-C) …

Previous studies have indicated that a G to A substitution at position-76 in the gene
encoding apolipoprotein AI (apoA-I) confers increased plasma high density lipoprotein …

We have determined the sequence of 250 bases 5'of the transcriptional start site of the
apolipoprotein AI gene in a human individual with high serum concentrations of apo AI. One …

We have investigated the association between serum high density lipoprotein-cholesterol
(HDL-C) and apo AI concentration and the Pstl and XmnI restriction fragment length …

The influence of the guanidine to adenine (G/A) substitution in the promoter region of the
apolipoprotein (apo) AI gene (at− 75 bp) on serum lipids and apolipoproteins was studied in …

Statins decrease cardiovascular morbidity and mortality, essentially, by reducing LDL-
cholesterol levels and, additionally, by increasing HDL-cholesterol concentrations …

An apolipoprotein AI gene promoter polymorphism, due to an adenine (A) to guanine (G)
transition 78 base pairs upstream from the transcription initiation site, was studied by …